This inventor holds 2 USPTO granted patents and 10 published patent applications and 2 EPO patents. Top assignee: Ultragenyx Pharmaceutical Inc.. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Christopher J Morrison: Innovator in Viral Particle Protection
Introduction
Christopher J Morrison is an accomplished inventor based in Arlington, MA (US). He has made significant contributions to the field of viral particle protection, particularly in the context of adeno-associated viruses (AAV). With a total of 2 patents to his name, Morrison's work is pivotal in advancing methods for ensuring the integrity of viral particles during heat inactivation processes.
Latest Patents
Morrison's latest patents focus on innovative methods of heat inactivation of adenovirus. The first patent outlines techniques for protecting the genomic integrity and biological activity of AAV viral particles in samples containing both AAV and helper virus particles during heat inactivation. The methods involve heating the sample to a temperature of 45°C or higher, utilizing a buffer that contains a concentration of 10 mM or greater of kosmotropic salts and/or divalent or trivalent cations. This approach is crucial for maintaining the viability of AAV particles in various applications.
Career Highlights
Morrison is currently employed at Ultragenyx Pharmaceutical Inc., where he continues to develop and refine his innovative methods. His expertise in viral particle protection has positioned him as a key figure in the pharmaceutical industry, contributing to advancements in gene therapy and related fields.
Collaborations
Morrison collaborates with notable professionals in his field, including his coworker James D Maratt. Their combined efforts enhance the research and development initiatives at Ultragenyx Pharmaceutical Inc., driving forward the company's mission to improve patient outcomes through innovative therapies.
Conclusion
Christopher J Morrison's contributions to the field of viral particle protection are significant and impactful. His patents and ongoing work at Ultragenyx Pharmaceutical Inc. demonstrate his commitment to advancing scientific knowledge and improving therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile